Table 1 Characteristics of the study participants according to their glucose regulation status and cystatin C levels.
Variables | All | Glucose regulation status | P | Cystatin C | P | ||
|---|---|---|---|---|---|---|---|
NGT | Prediabetes | < median | ≥ median | ||||
Number of participants | 146 | 72 | 74 | 73 | 73 | ||
Age, years | 58.8 ± 10.4 | 57.0 ± 9.9 | 60.6 ± 10.6 | 0.035 | 57.6 ± 10.9 | 60.1 ± 9.8 | 0.145 |
Male, n (%) | 121 (82.9) | 59 (81.9) | 62 (83.8) | 0.768 | 57 (78.1) | 64 (87.7) | 0.124 |
Body mass index, kg/m2 | 26.4 ± 3.6 | 26.1 ± 3.6 | 26.6 ± 3.6 | 0.401 | 25.8 ± 3.8 | 26.9 ± 3.4 | 0.063 |
Systolic BP, mm Hg | 125.8 ± 16.1 | 123.0 ± 17.4 | 128.4 ± 14.2 | 0.042 | 124.4 ± 16.0 | 127.1 ± 16.1 | 0.312 |
Diastolic BP, mm Hg | 74.5 ± 10.6 | 72.8 ± 11.1 | 76.2 ± 10.0 | 0.047 | 72.8 ± 11.6 | 76.2 ± 9.3 | 0.057 |
Smoking, n (%) | 31 (21.2) | 19 (26.4) | 12 (16.2) | 0.133 | 15 (20.5) | 16 (21.9) | 0.840 |
Hypertension, n (%) | 131 (89.7) | 60 (83.3) | 71 (95.9) | 0.012 | 65 (89.0) | 66 (90.4) | 0.785 |
Fasting plasma glucose, mg/dL | 92.9 ± 8.8 | 88.8 ± 6.0 | 96.8 ± 9.4 | < 0.001 | 93.1 ± 6.6 | 92.7 ± 10.7 | 0.794 |
2-h plasma glucose, mg/dL | 136.6 ± 34.4 | 110.4 ± 20.1 | 162.1 ± 24.8 | < 0.001 | 127.2 ± 31.2 | 146.0 ± 35.0 | 0.001 |
Total cholesterol, mg/dL | 188.5 ± 33.9 | 193.6 ± 35.7 | 183.5 ± 31.4 | 0.077 | 189.3 ± 33.4 | 188.5 ± 36.7 | 0.995 |
LDL cholesterol, mg/dL | 122.0 ± 31.5 | 126.9 ± 33.7 | 117.3 ± 28.7 | 0.067 | 119.8 ± 31.4 | 124.9 ± 32.6 | 0.267 |
HDL cholesterol, mg/dL | 47.3 ± 13.5 | 46.8 ± 13.0 | 47.7 ± 14.0 | 0.672 | 48.2 ± 14.3 | 45.6 ± 12.2 | 0.168 |
Triglyceride, mg/dL | 145.3 ± 83.3 | 145.7 ± 84.1 | 144.9 ± 83.1 | 0.954 | 149.8 ± 85.7 | 142.1 ± 80.2 | 0.646 |
eGFR, mL/min/1.73 m2 | 91.0 ± 14.3 | 92.5 ± 15.3 | 89.6 ± 13.3 | 0.225 | 91.2 ± 16.0 | 90.1 ± 12.3 | 0.466 |
UACR, mg/g | 14.1 ± 60.7 | 10.4 ± 21.7 | 17.7 ± 82.7 | 0.470 | 18.1 ± 71.9 | 18.3 ± 83.7 | 0.403 |
Albuminuria (≥ 30 mg/g), n (%) | 6 (4.1) | 4 (5.6) | 2 (2.7) | 0.385 | 4 (5.5) | 2 (2.7) | 0.404 |
Cystatin C, ng/mL | 564 ± 324 | 500 ± 321 | 627 ± 316 | 0.017 | 296 ± 230 | 831 ± 123 | < 0.001 |
Statin, N (%) | 24 (16.4) | 15 (20.8) | 9 (12.2) | 0.158 | 13 (17.8) | 11 (15.1) | 0.655 |
ACEI or ARB, n (%) | 71 (48.6) | 33 (45.8) | 38 (51.4) | 0.505 | 31 (42.5) | 40 (54.8) | 0.136 |